Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies.

Classical cytogenetic studies have a critical role in the diagnosis of acute leukemias; however, they are much less widely used in lymphoma diagnosis. To evaluate their utility in this latter setting, G-banded karyotyping was performed on 279 consecutive lymph node or tissue biopsy specimens with suspected lymphoma. Complete cytogenetic studies were successfully obtained in 177 cases (63.4%), including 115 (69.3%) of 166 hematolymphoid neoplasms. Success rates varied with the specific diagnosis (range, 33%-100%). The karyotypes were abnormal in 97 (84.3%) of the hematolymphoid neoplasms. In at least 3 cases of non-Hodgkin lymphoma, the findings contributed directly to the specific diagnosis made. In a much larger proportion of cases, characteristic but nonspecific findings were identified. Abnormalities of suggested prognostic importance in follicular lymphoma and in diffuse large B-cell lymphoma were identified in 14 (44%) of 32 cases and 8 (24%) of 33 cases, respectively. Most karyotyped lymphomas will display abnormal findings including many that are not completely specific but support the diagnosis, some that provide additional prognostic information, and, infrequently, some that help establish a diagnosis that might otherwise have been missed.

[1]  E. Elonen,et al.  Tumours of haematopoietic and lymphoid tissues: general guidelines , 2004 .

[2]  S. Swerdlow,et al.  T(14;18)(q32;q21) involving MALT1 and IGH genes in an extranodal diffuse large B-cell lymphoma. , 2003, Human pathology.

[3]  E. Haralambieva,et al.  Identification of chromosomal copy number changes associated with transformation of follicular lymphoma to diffuse large B-cell lymphoma. , 2003, Human pathology.

[4]  P. Gaulard,et al.  Gammadelta T-cell lymphomas. , 2003, Seminars in hematology (Print).

[5]  P. Gaulard,et al.  T-Cell Lymphomas , 2003 .

[6]  S. Swerdlow,et al.  Nodal marginal zone B-cell lymphoma with a novel t(X;5)(q28;q22): conventional and molecular cytogenetic analysis. , 2003, Cancer genetics and cytogenetics.

[7]  R. Gascoyne,et al.  Cytogenetic findings in reactive lymphoid hyperplasia: Significance of non‐clonal t(3;14) and t(3;22) , 2002, American journal of hematology.

[8]  M. Du,et al.  Gastric MALT lymphoma: from aetiology to treatment. , 2002, The Lancet. Oncology.

[9]  M. Du,et al.  Mucosa-associated lymphoid tissue lymphoma , 2002, Current opinion in hematology.

[10]  E. Berg,et al.  World Health Organization Classification of Tumours , 2002 .

[11]  R. Gascoyne,et al.  Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18) , 2001, Genes, chromosomes & cancer.

[12]  J. Teruya-Feldstein,et al.  Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. , 2000, Seminars in hematology.

[13]  M. Dyer,et al.  BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. , 2000, The American journal of pathology.

[14]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[15]  B. Jacobsson,et al.  Gain of chromosome 7, which marks the progression from indolent to aggressive follicle centre lymphomas, is restricted to the B‐lymphoid cell lineage: a study by FISH in combination with morphology and immunocytochemistry , 1999, British journal of haematology.

[16]  M. Piris,et al.  7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma. , 1999, The American journal of pathology.

[17]  R. Gascoyne,et al.  Small noncleaved, non-Burkitt's (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  B. Johansson,et al.  Prognostic implications of cytogenetic aberrations in diffuse large B‐cell lymphomas , 1999, European journal of haematology.

[19]  E. Campo,et al.  A marginal zone pattern may be found in different varieties of non‐Hodgkin's lymphoma: the morphology and immunohistology of splenic involvement by B‐cell lymphomas simulating splenic marginal zone lymphoma , 1998, Histopathology.

[20]  G. Juliusson,et al.  Cytogenetics in chronic lymphocytic leukemia. , 1998, Seminars in oncology.

[21]  L. Donner.  Cytogenetics of lymphomas: a brief review of its theoretical and practical significance. , 1997, Cancer genetics and cytogenetics.

[22]  F. Mitelman.  ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .

[23]  P. Isaacson,et al.  Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. , 1995, Blood.

[24]  Annick,et al.  Prognostic value of chromosomal abnormalities in follicular lymphoma. , 1994, Blood.

[25]  F. Mitelman.  ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics , 1992 .

[26]  S. Gollin,et al.  Atypical (7;19) translocation in acute myelomonocytic leukemia. , 1991, Cancer genetics and cytogenetics.

[27]  H. Tilly,et al.  Cytogenetic studies in untreated Hodgkin's disease. , 1991, Blood.

[28]  D. Weisenburger,et al.  Chromosomal abnormalities in Hodgkin's disease. , 1989, Blood.

[29]  M. Oken,et al.  Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. , 1987, The New England journal of medicine.